Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.

Saved in:
Bibliographic Details
Title: Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
Authors: Ortiz-Maldonado V; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Rives S; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain., Español-Rego M; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Alonso-Saladrigues A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Montoro M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Magnano L; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Giné E; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Pascal M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Díaz-Beyá M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Castella M; Banc de Sang i Teixits, Barcelona, Spain., Català A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain., Faura A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Rodríguez-Lobato LG; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Oliver-Caldes A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Martínez-Roca A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Rovira M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., González-Navarro EA; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Ortega JR; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Cid J; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Lozano M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Garcia-Rey E; Banc de Sang i Teixits, Barcelona, Spain., Fernández S; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Castro P; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Jordan I; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain., Villamor N; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Aymerich M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Torrebadell M; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Laboratory of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Deyà À; Clinical Immunology and Primary Immunodeficiencies Unit, Hospital Sant Joan de Déu, Barcelona, Spain., Fernández de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Benitez-Ribas D; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Trias E; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain., Varea S; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain., Calvo G; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain., Esteve J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Urbano-Ispizua A; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Juan M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain jdelgado@clinic.cat mjuan@clinic.cat.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Clinical Immunology Platform, Hospital Clínic-Sant Joan de Déu, Barcelona, Spain., Delgado J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain jdelgado@clinic.cat mjuan@clinic.cat.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Dec; Vol. 9 (12).
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2021-003644